Clinical Trial

Biomarker of Transdermal Vagus Nerve Stimulation

Study Description

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

The proposed project tests the hypothesis that salivary alpha amylase concentration is a reliable biomarker of the effect of transdermal vagus nerve stimulation (tVNS) in humans.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Transdermal Vagus Nerve Stimulation

intermittent transdermal stimulation of the aurical vagus

Additional Information

Official Study Title

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

Clinical Trial ID

NCT03854539

ParticipAid ID

eERXma